Cell C pleases market with maiden numbers

Cell C pleases market with maiden numbers

Cell C CEO Jorge Mendes. (Photograph by Nicola Mawson) Cell C’s maiden interim results for the period to end-November saw it deliver on its pre-listing statement, leading to a share price lift. “Delivering our first interim results as a listed company is an important milestone for Cell C. Our focus has been on executing with…

Read More
Africa: ‘Transplant Forensics’ – the Legal Imperative for Organ, Tissue and Cell Transplantation Reform in Africa

Africa: ‘Transplant Forensics’ – the Legal Imperative for Organ, Tissue and Cell Transplantation Reform in Africa

Organ, Tissue and Cell Donation and Transplantation (OTCDT) is a medical procedure in which an organ, tissue or cell is removed from one body and placed in the body of a recipient to replace a damaged or missing structure. Transplantation involves organs, tissues and cells such as the kidneys, liver, lungs, pancreas, heart, small bowel,…

Read More
2025 marks turning point for Cell C

2025 marks turning point for Cell C

2025 marked a turning point for Cell C, says the company. 2025 marked a turning point for Cell C, with the operator focusing on stabilising its business, strengthening network partnerships and refining its strategy in a highly competitive mobile market. In an e-mail interview with ITWeb, Cell C CEO Jorge Mendes says: “We returned to…

Read More
PICS: Cell C lists on the JSE

PICS: Cell C lists on the JSE

Cell C CEO Jorge Mendes addresses the audience at the JSE as the telco lists. (Photograph by Nicola Mawson) As Cell C listed on the JSE this morning, almost 4 000 shares traded within minutes of the market opening, with the stock debuting at R27 – a 50c per share improvement on the final pre-listing…

Read More